Boosting Flu Vaccination Rates: Effective Nudge Strategies for Heart Attack Survivors

Research Highlights on Flu Vaccination and Cardiac Benefits

1. An electronic message encouraging flu vaccination improved rates among over 2 million adults in Denmark.
2. This nudge was particularly effective for individuals with a history of heart attacks.
3. The study suggests that this low-cost approach can enhance vaccination rates globally.

Study Overview

On November 17, 2024, a study presented at the American Heart Association’s Scientific Sessions revealed that electronic letters—called nudges—focused on the cardiovascular benefits of influenza vaccines increased vaccination rates significantly during the 2022-2023 and 2023-2024 flu seasons in Denmark.

Key Findings

• The study assessed the effectiveness of electronic reminders through three trials (NUDGE-FLU, NUDGE-FLU-2, NUDGE-FLU CHRONIC).
• Participants received either a nudge email or standard care. Those who received the nudge showed higher vaccination rates.
• Heart attack survivors experienced a 1.8% increase in vaccination, while those without a history of heart attack saw a 1.3% increase.
• A message emphasizing the cardiovascular benefits resulted in a 3.9% increase among heart attack survivors, compared to a 2% increase for others.
• Among unvaccinated heart attack survivors, the nudge led to almost a 14% increase in vaccination rates.
• Younger adults with recent heart attacks also showed a notable response, with a 26% increase in vaccinations.

Conclusion

The study’s lead researcher, Dr. Ankeet Bhatt, emphasized the potential of this simple electronic intervention to improve vaccination rates, making it a valuable strategy in public health. However, he noted that additional strategies may be necessary to fully address gaps in flu vaccination, especially in regions with lower rates.

Implications for Public Health

Given its effectiveness, this low-cost approach should be explored in other countries as a way to increase flu vaccination rates. More research is needed to understand its impact in areas with lower baseline vaccination rates.

Study Details

• The trials included over 2 million adults, ages 18-64.
• More than 59,450 participants had a history of heart attacks, with an average age of 70.

The findings highlight a promising method to improve health outcomes for at-risk populations through clear communication about the benefits of vaccines.